These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8582893)

  • 1. Clinical perspectives of platelet transfusions: defining the optimal dose.
    Strauss RG
    J Clin Apher; 1995; 10(3):124-7. PubMed ID: 8582893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The definition of refractoriness to platelet transfusions.
    Bishop JF; Matthews JP; Yuen K; McGrath K; Wolf MM; Szer J
    Transfus Med; 1992 Mar; 2(1):35-41. PubMed ID: 1308461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.
    Kelly AM; Garner SF; Foukaneli T; Godec TR; Herbert N; Kahan BC; Deary A; Bakrania L; Llewelyn C; Ouwehand WH; Williamson LM; Cardigan RA
    Blood; 2017 Jul; 130(2):214-220. PubMed ID: 28487294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
    Hirooka M; Ochi H; Hiraoka A; Koizumi Y; Tanaka T; Sunago K; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Abe M; Joko K; Michitaka K; Hiasa Y
    J Gastroenterol Hepatol; 2020 Feb; 35(2):299-304. PubMed ID: 31318996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
    Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
    Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.